<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[healthcare Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/healthcare.html]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to healthcare]]></description>
	<s:counts start="0" returned="20" found="42916" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Doctors Fight For Their Piece of The Healthcare Pie]]></title>
		<link><![CDATA[http://industry.bnet.com/healthcare/10001463/doctors-fight-for-their-piece-of-the-healthcare-pie/]]></link>
		<description><![CDATA[Physicians are opposed to provisions in the Senate healthcare reform bill that would threaten their incomes, now or in the future. by Ken Terry]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Fri, 04 Dec 2009 15:35:27 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/health+care.html"><![CDATA[Health Care]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare+reform.html"><![CDATA[Healthcare Reform]]></category>
		<category domain="http://resources.bnet.com/topic/operational+accounting.html"><![CDATA[Operational Accounting]]></category>
		<category domain="http://resources.bnet.com/topic/personal+finance.html"><![CDATA[Personal Finance]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/ken+terry.html"><![CDATA[Ken Terry]]></category>
	</item>
	<item>
		<title><![CDATA[Notes from Accuray Annual Shareholder Meeting (2009)]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F176571-notes-from-accuray-annual-shareholder-meeting-2009%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Matthew Rafat submits:  I attended Accuray's ARAY annual shareholder meeting on November 20, 2009. The Palo Alto, California law firm of Wilson Sonsini Goodrich & Rosati hosted the meeting. The law firm provided coffee, orange juice, pastries, and fruit for shareholders. Accuray sells "CyberKnife," which is used to remove...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Fri, 04 Dec 2009 04:21:13 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/matthew+rafat.html"><![CDATA[Matthew Rafat]]></category>
		<category domain="http://resources.bnet.com/topic/accuray+inc..html"><![CDATA[Accuray Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ARAY</category>
		<category domain="tickers">ARAY</category>
	</item>
	<item>
		<title><![CDATA[AstraZeneca, Targacept Teaming Up for New Antidepressant]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F176653-astrazeneca-targacept-teaming-up-for-new-antidepressant%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Zacks.com submits:   AstraZeneca AZN and Targacept TRGT have taken a significant step in the multi-billion dollar antidepressant market. The two companies entered into a collaboration and license agreement regarding the development of a drug targeted towards major depressive disorder MDD. The drug, TC-5214, Targacept&#8217;s late-stage investigational product, recently...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Fri, 04 Dec 2009 01:28:02 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/zacks.com.html"><![CDATA[Zacks.com]]></category>
		<category domain="http://resources.bnet.com/topic/astrazeneca+plc..html"><![CDATA[AstraZeneca Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/targacept+inc..html"><![CDATA[Targacept Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">TRGT</category>
		<category domain="tickers">AZN,TRGT</category>
	</item>
	<item>
		<title><![CDATA[Medicare D and Medicare Advantage: How to Pick Plans]]></title>
		<link><![CDATA[http://moneywatch.bnet.com/retirement-planning/article/medicare-d-and-medicare-advantage-how-to-pick-plans/370065/]]></link>
		<description><![CDATA[Time is running out for you or your parents to sign up for Medicare D and Medicare Advantage plans. By following these tips, you?ll be able to find the best and most affordable coverage.        As painful as it may be to sift through...]]></description>
		<s:doctype><![CDATA[Articles]]></s:doctype>
		<pubDate>Fri, 04 Dec 2009 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/medicare.html"><![CDATA[Medicare]]></category>
		<category domain="http://resources.bnet.com/topic/plan.html"><![CDATA[Plan]]></category>
		<category domain="http://resources.bnet.com/topic/moneywatch.html"><![CDATA[MoneyWatch]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/medicare+d.html"><![CDATA[Medicare D]]></category>
		<category domain="http://resources.bnet.com/topic/medicare+advantage.html"><![CDATA[Medicare Advantage]]></category>
		<category domain="http://resources.bnet.com/topic/open+enrollment.html"><![CDATA[Open Enrollment]]></category>
		<category domain="http://resources.bnet.com/topic/prescription+drugs.html"><![CDATA[Prescription Drugs]]></category>
		<category domain="http://resources.bnet.com/topic/kaiser+family+foundation.html"><![CDATA[Kaiser Family Foundation]]></category>
		<category domain="http://resources.bnet.com/topic/unitedhealth+group.html"><![CDATA[UnitedHealth Group]]></category>
		<category domain="http://resources.bnet.com/topic/wellcare+health+plans.html"><![CDATA[WellCare Health Plans]]></category>
		<category domain="http://resources.bnet.com/topic/mark+miller.html"><![CDATA[Mark Miller]]></category>
		<category domain="http://resources.bnet.com/topic/medigap.html"><![CDATA[Medigap]]></category>
		<category domain="http://resources.bnet.com/topic/aarp.html"><![CDATA[AARP]]></category>
		<category domain="http://resources.bnet.com/topic/doughnut+hole.html"><![CDATA[Doughnut Hole]]></category>
		<category domain="http://resources.bnet.com/topic/doughnut+hole+calculator.html"><![CDATA[Doughnut Hole Calculator]]></category>
		<category domain="http://resources.bnet.com/topic/medicare.gov.html"><![CDATA[Medicare.gov]]></category>
		<category domain="http://resources.bnet.com/topic/medicare+prescription+drug+plan+finder.html"><![CDATA[Medicare Prescription Drug Plan Finder]]></category>
		<category domain="http://resources.bnet.com/topic/medicare+%2526+you.html"><![CDATA[Medicare & You]]></category>
		<category domain="http://resources.bnet.com/topic/state+health+insurance+assistance+programs.html"><![CDATA[State Health Insurance Assistance Programs]]></category>
		<category domain="http://resources.bnet.com/topic/medicare+rights+center.html"><![CDATA[Medicare Rights Center]]></category>
		<category domain="http://resources.bnet.com/topic/allsup+medicare+advisor.html"><![CDATA[Allsup Medicare Advisor]]></category>
		<category domain="http://resources.bnet.com/topic/health+assistance+partnership.html"><![CDATA[Health Assistance Partnership]]></category>
		<category domain="http://resources.bnet.com/topic/stacey+bradford.html"><![CDATA[Stacey Bradford]]></category>
	</item>
	<item>
		<title><![CDATA[COBRA Subsidies Should Be Extended]]></title>
		<link><![CDATA[http://industry.bnet.com/healthcare/10001461/cobra-subsidies-should-be-extended/]]></link>
		<description><![CDATA[Congress should extend the COBRA subsidy law to help millions of unemployed people who would otherwise lose their health insurance. by Ken Terry]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Thu, 03 Dec 2009 15:08:41 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/benefits.html"><![CDATA[Benefits]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/insurance.html"><![CDATA[Insurance]]></category>
		<category domain="http://resources.bnet.com/topic/payroll+solutions.html"><![CDATA[Payroll Solutions]]></category>
		<category domain="http://resources.bnet.com/topic/vertical+industries.html"><![CDATA[Vertical Industries]]></category>
		<category domain="http://resources.bnet.com/topic/human+resources.html"><![CDATA[Human Resources]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://resources.bnet.com/topic/corporate+insurance.html"><![CDATA[Corporate Insurance]]></category>
		<category domain="http://resources.bnet.com/topic/ken+terry.html"><![CDATA[Ken Terry]]></category>
	</item>
	<item>
		<title><![CDATA[Pfizer Blasted in Canada for $780K CME Program]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10005653/pfizer-blasted-in-canada-for-780k-cme-program/]]></link>
		<description><![CDATA[Pfizer PFE can't catch a break in Canada right now. It's being blasted for a C$780,000 continuing medical education program it has set up through the Canadian Medical Association. Critics believe that doctor education should not be influenced by drug companies, which have a different set of interests than patients....]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Thu, 03 Dec 2009 13:51:55 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/health+care.html"><![CDATA[Health Care]]></category>
		<category domain="http://resources.bnet.com/topic/vertical+industries.html"><![CDATA[Vertical Industries]]></category>
		<category domain="http://resources.bnet.com/topic/benefits.html"><![CDATA[Benefits]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/human+resources.html"><![CDATA[Human Resources]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="tickers">PFE</category>
	</item>
	<item>
		<title><![CDATA[CytRx Corporation: A Solid Rebound Play?]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F176288-cytrx-corporation-a-solid-rebound-play%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[As anticipated and reported by BioMedReports on Novermber 23rd, CytRx Corporation (NASDAQ:CYTR) appears to be shaping up into quite a rebound story. Yesterday morning, officials at the company have announced that they are permitted to re-enter the clinic with its orally administered molecular chaperone drug candidate arimoclomol as a therapeutic...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Thu, 03 Dec 2009 12:53:06 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/m.+e.+garza.html"><![CDATA[M. E. Garza]]></category>
		<category domain="http://resources.bnet.com/topic/cytrx+corp..html"><![CDATA[CytRx Corp.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CYTR</category>
		<category domain="tickers">CYTR</category>
	</item>
	<item>
		<title><![CDATA[Human Genome Sciences: Can the Volatility Continue?]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F176420-human-genome-sciences-can-the-volatility-continue%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[optionMONSTER submits:   By Chris McKhann Human Genome Sciences HGSI is up 6,300% from its March low, but at least one trader is apparently making a bet that the volatility will subside. by optionMONSTER]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Thu, 03 Dec 2009 09:46:48 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/optionmonster.html"><![CDATA[optionMONSTER]]></category>
		<category domain="http://resources.bnet.com/topic/human+genome+sciences+inc..html"><![CDATA[Human Genome Sciences Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">HGSI</category>
		<category domain="tickers">HGSI</category>
	</item>
	<item>
		<title><![CDATA[Genzyme: Positive Development on the Lumizyme Front]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F176466-genzyme-positive-development-on-the-lumizyme-front%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Thursday morning, Genzyme GENZ announced that it had met with the FDA regarding the regulatory path forward for approval of Pompe disease drug Lumizyme. It was decided that the most expiditious path forward would be to submit a BLA for the 4000L-produced Lumizyme (instead of seeking approval for the 2000L-produced...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Thu, 03 Dec 2009 02:34:09 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/mark+mitchell.html"><![CDATA[Mark Mitchell]]></category>
		<category domain="http://resources.bnet.com/topic/genzyme+corp..html"><![CDATA[Genzyme Corp.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GENZ</category>
		<category domain="tickers">GENZ</category>
	</item>
	<item>
		<title><![CDATA[The 10 Weirdest Drug Stories of the Month]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10005620/the-10-weirdest-drug-stories-of-the-month-15/]]></link>
		<description><![CDATA[A vaccine for smoking! Power hungry Eli Lilly execs! Flu shots from caterpillars! It all happened in November 2009.    	Biogen CEO pay = $148 million for 6 years  Letter to the SEC: "CEO, James Mullen, has sold more than $85 million of stock, which we estimate...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Wed, 02 Dec 2009 16:46:27 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/eli+lilly+%2526+co..html"><![CDATA[Eli Lilly & Co.]]></category>
		<category domain="http://resources.bnet.com/topic/vaccine.html"><![CDATA[Vaccine]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/gender+and+diversity.html"><![CDATA[Gender And Diversity]]></category>
		<category domain="http://resources.bnet.com/topic/human+resources.html"><![CDATA[Human Resources]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
		<category domain="tickers">LLY</category>
	</item>
	<item>
		<title><![CDATA[Medicare Cuts Do Not Have to Endanger Care]]></title>
		<link><![CDATA[http://industry.bnet.com/healthcare/10001457/medicare-cuts-do-not-have-to-endanger-care/]]></link>
		<description><![CDATA[The $500 million that the Senate bill would take out of Medicare spending could be found by cutting waste in the program. by Ken Terry]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Wed, 02 Dec 2009 14:08:06 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/medicare.html"><![CDATA[Medicare]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/ken+terry.html"><![CDATA[Ken Terry]]></category>
	</item>
	<item>
		<title><![CDATA[Ex-BusinessWeek EIC Adler Joins Thomson Reuters]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fpaidcontent.org%2Farticle%2F419-ex-businessweek-eic-adler-joins-thomson-reuters%2F&siteid=23&tag=contentnext]]></link>
		<description><![CDATA[  Stephen J. Adler, who resigned his post as editor-in-chief of BusinessWeek shortly after the magazine&#8217;s sale to Bloomberg, is taking a new role at Thomson Reuters (NYSE: TRI). Adler will become SVP and editorial director of the news service&#8217;s Professional division, which covers Legal, Tax & Accounting, and...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Wed, 02 Dec 2009 13:48:46 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/thomson+reuters+corp..html"><![CDATA[Thomson Reuters Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/businessweek.html"><![CDATA[BusinessWeek]]></category>
		<category domain="http://resources.bnet.com/topic/bloomberg+l.p..html"><![CDATA[Bloomberg L.P.]]></category>
		<category domain="http://resources.bnet.com/topic/taxes.html"><![CDATA[Taxes]]></category>
		<category domain="http://resources.bnet.com/topic/free+trade.html"><![CDATA[Free Trade]]></category>
		<category domain="http://resources.bnet.com/topic/vertical+industries.html"><![CDATA[Vertical Industries]]></category>
		<category domain="http://resources.bnet.com/topic/benefits.html"><![CDATA[Benefits]]></category>
		<category domain="http://resources.bnet.com/topic/personal+finance.html"><![CDATA[Personal Finance]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/financial+planning.html"><![CDATA[Financial Planning]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/human+resources.html"><![CDATA[Human Resources]]></category>
		<category domain="http://resources.bnet.com/topic/industry+moves.html"><![CDATA[Industry Moves]]></category>
		<category domain="http://resources.bnet.com/topic/media+%2526+publishing.html"><![CDATA[Media & Publishing]]></category>
		<category domain="http://resources.bnet.com/topic/magazines.html"><![CDATA[Magazines]]></category>
		<category domain="http://resources.bnet.com/topic/companies.html"><![CDATA[Companies]]></category>
		<category domain="http://resources.bnet.com/topic/reuters.html"><![CDATA[Reuters]]></category>
		<category domain="http://resources.bnet.com/topic/david+kaplan.html"><![CDATA[David Kaplan]]></category>
	</item>
	<item>
		<title><![CDATA[Titan Pharmaceutical: More Likely Buyout Target as Patent Protection Is Approved]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F176196-titan-pharmaceutical-more-likely-buyout-target-as-patent-protection-is-approved%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[VFC submits:  Titan Pharmaceuticals (TTNP.PK) announced on Monday that the company had received confirmation from the United States Patent and Trademark Office [USPTO] that a Notice of Allowance had been issued for Probuphine for the treatment of Opiate addiction. This news has been long awaited and heavily anticipated by...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Wed, 02 Dec 2009 10:12:33 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/vfc%2527s+stock+house.html"><![CDATA[VFC's Stock House]]></category>
	</item>
	<item>
		<title><![CDATA[Jobless Face Huge Hike in Health Premiums; Seven Steps to Dodge the Threat]]></title>
		<link><![CDATA[http://moneywatch.bnet.com/saving-money/blog/devil-details/jobless-face-huge-hike-in-health-premiums-seven-steps-to-dodge-the-threat/1109/]]></link>
		<description><![CDATA[Millions of jobless Americans face a huge hike in health insurance premiums because of the expiration of a COBRA subsidy that was created last February. The subsidy could be extended, but experts say you should consider a contingency plan, if you want to keep your health insurance affordable. by Kathy...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Wed, 02 Dec 2009 07:23:57 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/health+insurance.html"><![CDATA[Health Insurance]]></category>
		<category domain="http://resources.bnet.com/topic/health+care.html"><![CDATA[Health Care]]></category>
		<category domain="http://resources.bnet.com/topic/hike.html"><![CDATA[Hike]]></category>
		<category domain="http://resources.bnet.com/topic/benefits.html"><![CDATA[Benefits]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/insurance.html"><![CDATA[Insurance]]></category>
		<category domain="http://resources.bnet.com/topic/vertical+industries.html"><![CDATA[Vertical Industries]]></category>
		<category domain="http://resources.bnet.com/topic/payroll+solutions.html"><![CDATA[Payroll Solutions]]></category>
		<category domain="http://resources.bnet.com/topic/human+resources.html"><![CDATA[Human Resources]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://resources.bnet.com/topic/corporate+insurance.html"><![CDATA[Corporate Insurance]]></category>
		<category domain="http://resources.bnet.com/topic/kathy+kristof.html"><![CDATA[Kathy Kristof]]></category>
	</item>
	<item>
		<title><![CDATA[McDonald's COO Alvarez to Retire, Cites Health]]></title>
		<link><![CDATA[http://www.bnet.com/2407-14040_23-369372.html]]></link>
		<description><![CDATA[By Lisa BaertleinLOS ANGELES (<a href="http://resources.bnet.com/index.php?source=Reuters">Reuters</a>) - McDonald's Corp MCD Chief Operating Officer Ralph Alvarez, who was widely believed to be in line for the fast-food chain's top job, will retire on December 31 due to health reasons, the company said on Tuesday."Seven orthopedic surgeries and years of chronic pain culminating...]]></description>
		<s:doctype><![CDATA[News items]]></s:doctype>
		<pubDate>Tue, 01 Dec 2009 18:45:45 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/health+care.html"><![CDATA[Health Care]]></category>
		<category domain="http://resources.bnet.com/topic/mcdonald%2527s+corp..html"><![CDATA[McDonald's Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/vertical+industries.html"><![CDATA[Vertical Industries]]></category>
		<category domain="http://resources.bnet.com/topic/benefits.html"><![CDATA[Benefits]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/human+resources.html"><![CDATA[Human Resources]]></category>
		<category domain="http://resources.bnet.com/topic/mcdonalds.html"><![CDATA[Mcdonalds]]></category>
		<category domain="http://resources.bnet.com/topic/us.html"><![CDATA[Us]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MCD</category>
		<category domain="tickers">MCD</category>
	</item>
	<item>
		<title><![CDATA[Merck KGaA: Another Stumble Leaves Investors Worried]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F175962-merck-kgaa-another-stumble-leaves-investors-worried%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[EP Vantage submits: It was the kind of news that Merck KGaA (MKGAY.PK) could have done without following its failure last week to get European approval for Erbitux in lung cancer.  As such, the bombshell that the FDA had issued a refuse to file letter in response to the...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Tue, 01 Dec 2009 09:08:22 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/ep+vantage.html"><![CDATA[EP Vantage]]></category>
		<category domain="http://resources.bnet.com/topic/novartis+ag.html"><![CDATA[Novartis AG]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NVS</category>
		<category domain="tickers">NVS</category>
	</item>
	<item>
		<title><![CDATA[AstraZeneca's Latest Cost-Cutting Move: Offshore Production]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F175916-astrazeneca-s-latest-cost-cutting-move-offshore-production%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[ChinaBio Today submits:  In a continuing attempt to cut costs, the Anglo-Swedish big pharma AstraZeneca (NYSE: AZN) said it would move all of its API production offshore, with most of it going to China. The company will close a plant in the UK that manufactures APIs for cholesterol and...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Tue, 01 Dec 2009 06:11:22 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/chinabio+today.html"><![CDATA[ChinaBio Today]]></category>
		<category domain="http://resources.bnet.com/topic/astrazeneca+plc..html"><![CDATA[AstraZeneca Plc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
		<category domain="tickers">AZN</category>
	</item>
	<item>
		<title><![CDATA[Incyte's Collaboration with Novartis AG Presents Great Opportunity]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F175906-incyte-s-collaboration-with-novartis-ag-presents-great-opportunity%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Zacks.com submits:   Incyte Corporation INCY entered into a collaboration and license agreement with Novartis AG NVS regarding two of its pipeline candidates &#8211; INCB18424, an oral JAK1/JAK2 inhibitor and INCB28060, an oral cMET inhibitor. While the former is currently being studied in a phase III clinical trial for...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Tue, 01 Dec 2009 05:45:25 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/zacks.com.html"><![CDATA[Zacks.com]]></category>
		<category domain="http://resources.bnet.com/topic/incyte+corp..html"><![CDATA[Incyte Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/novartis+ag.html"><![CDATA[Novartis AG]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">INCY</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NVS</category>
		<category domain="tickers">INCY,NVS</category>
	</item>
	<item>
		<title><![CDATA[Preventative Medicine May Be Universal Healthcare's Panacea]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F175900-preventative-medicine-may-be-universal-healthcare-s-panacea%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Jim Delaney submits:   &#8220;Just learn to live with it, mate,&#8221; was what T.R. Reid heard when he visited his doctor in Britain.  A scary response for most Americans when comparisons are made between what could soon be known as health care in this country and what exists...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Tue, 01 Dec 2009 05:32:35 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/jim+delaney.html"><![CDATA[Jim Delaney]]></category>
	</item>
	<item>
		<title><![CDATA[Cepheid Narrows Loss in Q3]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F175674-cepheid-narrows-loss-in-q3%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Zacks.com submits:   Cepheid&#8217;s CPHD third quarter net loss per share of 6 cents was much better than the Zacks Consensus Estimate of 12 cents as well as a loss of 12 cents reported in the third quarter of 2009. Although revenues for the quarter came down by 7%...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Mon, 30 Nov 2009 12:59:22 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/zacks.com.html"><![CDATA[Zacks.com]]></category>
		<category domain="http://resources.bnet.com/topic/cepheid.html"><![CDATA[Cepheid]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CPHD</category>
		<category domain="tickers">CPHD</category>
	</item>
</channel>
</rss>
